Schnieders Capital Management LLC Sells 268 Shares of CVS Health Co. (NYSE:CVS)

Schnieders Capital Management LLC trimmed its stake in CVS Health Co. (NYSE:CVS) by 5.8% during the 4th quarter, HoldingsChannel.com reports. The firm owned 4,347 shares of the pharmacy operator’s stock after selling 268 shares during the period. Schnieders Capital Management LLC’s holdings in CVS Health were worth $343,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Bryn Mawr Capital Management LLC grew its position in CVS Health by 74.0% in the 3rd quarter. Bryn Mawr Capital Management LLC now owns 43,213 shares of the pharmacy operator’s stock worth $3,017,000 after purchasing an additional 18,385 shares during the last quarter. Value Partners Investments Inc. lifted its holdings in CVS Health by 26.5% during the 3rd quarter. Value Partners Investments Inc. now owns 991,601 shares of the pharmacy operator’s stock valued at $69,261,000 after purchasing an additional 207,702 shares during the last quarter. Sonora Investment Management Group LLC lifted its holdings in CVS Health by 1.6% during the 3rd quarter. Sonora Investment Management Group LLC now owns 50,488 shares of the pharmacy operator’s stock valued at $3,525,000 after purchasing an additional 774 shares during the last quarter. Checchi Capital Advisers LLC lifted its holdings in CVS Health by 2.3% during the 3rd quarter. Checchi Capital Advisers LLC now owns 10,405 shares of the pharmacy operator’s stock valued at $726,000 after purchasing an additional 233 shares during the last quarter. Finally, Personal CFO Solutions LLC raised its stake in shares of CVS Health by 2.6% in the third quarter. Personal CFO Solutions LLC now owns 19,355 shares of the pharmacy operator’s stock worth $1,351,000 after acquiring an additional 491 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Down 1.1 %

Shares of CVS Health stock traded down $0.73 on Wednesday, hitting $67.77. The company had a trading volume of 8,645,334 shares, compared to its average volume of 10,730,963. The firm has a market capitalization of $85.42 billion, a P/E ratio of 10.52, a P/E/G ratio of 0.92 and a beta of 0.52. CVS Health Co. has a twelve month low of $64.41 and a twelve month high of $83.25. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.86 and a quick ratio of 0.63. The stock has a 50-day moving average of $74.97 and a 200-day moving average of $73.76.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share for the quarter, beating the consensus estimate of $2.01 by $0.11. The company had revenue of $93.81 billion during the quarter, compared to analysts’ expectations of $90.58 billion. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The business’s quarterly revenue was up 11.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.99 earnings per share. Research analysts predict that CVS Health Co. will post 8.31 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Investors of record on Monday, April 22nd will be issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.93%. The ex-dividend date of this dividend is Friday, April 19th. CVS Health’s payout ratio is 41.18%.

Insider Buying and Selling

In related news, EVP Prem S. Shah sold 29,473 shares of the stock in a transaction on Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the completion of the transaction, the executive vice president now owns 39,765 shares in the company, valued at $3,059,916.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.24% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on CVS. Piper Sandler boosted their target price on shares of CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a research note on Friday, March 15th. StockNews.com downgraded shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Thursday, February 15th. SVB Leerink began coverage on shares of CVS Health in a research note on Monday, February 26th. They issued an “outperform” rating and a $88.00 target price for the company. Cantor Fitzgerald reissued an “overweight” rating and set a $87.00 price target on shares of CVS Health in a research note on Wednesday, April 10th. Finally, Barclays began coverage on shares of CVS Health in a research note on Wednesday, March 6th. They set an “equal weight” rating and a $78.00 price target for the company. Four analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $89.44.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.